Paper42792016PubMed
Predictors of In-Hospital Mortality Among Hospitalized Colistin-Treated Patients at a Tertiary Urology-Nephrology Referral Center.
Radu VD and 14 others. Antibiotics (Basel), 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Predictors of In-Hospital Mortality Among Hospitalized Colistin-Treated Patients at a Tertiary Urology-Nephrology Referral Center. Papers, record 42792016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42792016
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predictors of In-Hospital Mortality Among Hospitalized Colistin-Treated Patients at a Tertiary Urology-Nephrology Referral Center.
- Journal
- Antibiotics (Basel)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-09-29
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,533,669 | Optimal dosing interval of intravenous Colistin monotherapy versus combination therapy: A systematic review and meta-analysis. | Eur J Transl Myol | 2022 | https://conductscience.org/library/papers/36533669 | PubMed |
| 2 | 36,857,834 | A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic. | J Infect Public Health | 2023 | https://conductscience.org/library/papers/36857834 | PubMed |
| 3 | 33,276,108 | Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/33276108 | PubMed |
| 4 | 40,245,910 | The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. | Lancet Infect Dis | 2025 | https://conductscience.org/library/papers/40245910 | PubMed |
| 5 | 39,081,869 | Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/39081869 | PubMed |
| 6 | 36,774,938 | Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. | Lancet Microbe | 2023 | https://conductscience.org/library/papers/36774938 | PubMed |
| 7 | 38,183,224 | Reviewing novel treatment options for carbapenem-resistant Enterobacterales. | Expert Rev Anti Infect Ther | 2024 | https://conductscience.org/library/papers/38183224 | PubMed |
| 8 | 35,255,988 | Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021). | Antimicrob Resist Infect Control | 2022 | https://conductscience.org/library/papers/35255988 | PubMed |
| 9 | 41,201,487 | Nephrotoxicity of polymyxin B and colistin sulfate in patients with multidrug-resistant gram-negative bacteria infections: a parametric time-to-event analysis. | Int J Clin Pharm | 2026 | https://conductscience.org/library/papers/41201487 | PubMed |
| 10 | 35,781,159 | Effects of Bacterial Urinary Tract Infection on Clinical Outcome and Survival of Kidney Transplant Patients. | Transplant Proc | 2022 | https://conductscience.org/library/papers/35781159 | PubMed |
| 11 | 41,011,759 | Emergence of Carbapenem-Resistant Klebsiella pneumoniae in a Romanian Infectious Diseases Hospital. | Pathogens | 2025 | https://conductscience.org/library/papers/41011759 | PubMed |
| 12 | 32,781,593 | Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32781593 | PubMed |
| 13 | 41,009,897 | Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41009897 | PubMed |
| 14 | 36,009,935 | The Effect of Different Colistin Dosing Regimens on Nephrotoxicity: A Cohort Study. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36009935 | PubMed |
| 15 | 42,112,222 | Antimicrobial resistance trends during COVID-19 in male patients: a descriptive analysis. | J Med Life | 2026 | https://conductscience.org/library/papers/42112222 | PubMed |
| 16 | 26,903,338 | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | JAMA | 2016 | https://conductscience.org/library/papers/26903338 | PubMed |
| 17 | 35,065,702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
| 18 | 36,088,407 | Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections. | Sci Rep | 2022 | https://conductscience.org/library/papers/36088407 | PubMed |
| 19 | 39,299,261 | Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. | Lancet | 2024 | https://conductscience.org/library/papers/39299261 | PubMed |
| 20 | 36,388,829 | Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/36388829 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42792016
GET https://conductscience.org/api/papers/v1/42792016/references?page=2